
Tender: Supply of Anti‑Cancer and Allied/Supportive Medicines — Abbottabad (FY 2026‑27)
Tender · Abbottabad · Jang,
Tender advertisement published in Jang on Tuesday, 15 September 2026, listed under Abbottabad, Pakistan. The last date printed on the advertisement was Saturday, 3 October 2026 and has passed.
The original image is temporarily unavailable. Use the source link or the details below. Open the full-size clipping Advertisement details
Issuer: Administrator, Procurement Branch, P.O. Box 110, Abbottabad. Sealed tenders (No. 01/2026-27) are invited for the supply of Anti‑Cancer and Allied/Supportive medicines for the Financial Year 2026-27 (estimated value Rs. 471.65 million, approximately) with a 4‑month grace period up to 2027-10-31 or until hiring of new contractor(s).
| Tender No. | 01/2026-27 |
|---|---|
| Subject | Supply of Anti‑Cancer and Allied/Supportive Medicines |
| Estimated Value | Rs. 471.65 Million (approximately) |
| Eligibility | Reputed pharmaceutical manufacturers, importers, sole country‑wise distributors and local distributors with active NTN and a valid drug license |
| Tender document fee | Rs. 500 (non‑refundable) in person; Rs. 650 by mail (Demand Draft / Pay Order payable to Sr. Accounts Officer, P.O. Box 110, Abbottabad) |
| Earnest Money | 2% of quoted amount as Demand Draft / Pay Order in favour of Sr. Accounts Officer, P.O. Box 110, Abbottabad |
| Documents available from | Procurement Branch, P.O. Box 110, Abbottabad during working hours |
| Submission address & deadline | Administrator, P.O. Box 110, Abbottabad — must reach by 2026-10-03 (Saturday) at 10:00 hrs |
| Opening | 2026-10-03 at 11:00 hrs (same day) — bidders/representatives may attend |
| Contact | Phone: 0992-9311029-30 |
Note: In case of an unplanned/unforeseen public holiday the tender will be opened on the next working day at the stated time.
Published in Jang on Tuesday, 15 September 2026. DailyAds.pk indexes newspaper advertisements; the original notice and the issuing organisation remain the source for final terms and eligibility.










